Improving preparedness to respond to cross-border hepatitis A outbreaks in the European Union/European Economic Area: towards comparable sequencing of hepatitis A virus.
European Union
HAV
capacity building
foodborne diseases
hepatitis A virus
sequence analysis
surveys and questionnaires
Journal
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
entrez:
18
7
2019
pubmed:
18
7
2019
medline:
17
7
2020
Statut:
ppublish
Résumé
IntroductionSequence-based typing of hepatitis A virus (HAV) is important for outbreak detection, investigation and surveillance. In 2013, sequencing was central to resolving a large European Union (EU)-wide outbreak related to frozen berries. However, as the sequenced HAV genome regions were only partly comparable between countries, results were not always conclusive.AimThe objective was to gather information on HAV surveillance and sequencing in EU/European Economic Area (EEA) countries to find ways to harmonise their procedures, for improvement of cross-border outbreak responses.MethodsIn 2014, the European Centre for Disease Prevention and Control (ECDC) conducted a survey on HAV surveillance practices in EU/EEA countries. The survey enquired whether a referral system for confirming primary diagnostics of hepatitis A existed as well as a central collection/storage of hepatitis A cases' samples for typing. Questions on HAV sequencing procedures were also asked. Based on the results, an expert consultation proposed harmonised procedures for cross-border outbreak response, in particular regarding sequencing. In 2016, a follow-up survey assessed uptake of suggested methods.ResultsOf 31 EU/EEA countries, 23 (2014) and 27 (2016) participated. Numbers of countries with central collection and storage of HAV positive samples and of those performing sequencing increased from 12 to 15 and 12 to 14 respectively in 2016, with all countries typing an overlapping fragment of 218 nt. However, variation existed in the sequenced genomic regions and their lengths.ConclusionsWhile HAV sequences in EU/EEA countries are comparable for surveillance, collaboration in sharing and comparing these can be further strengthened.
Identifiants
pubmed: 31311618
doi: 10.2807/1560-7917.ES.2019.24.28.1800397
pmc: PMC6636214
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Commentaires et corrections
Type : CommentIn
Références
J Virol. 2002 Sep;76(18):9516-25
pubmed: 12186933
J Gen Virol. 1992 Jun;73 ( Pt 6):1365-77
pubmed: 1318940
Vaccine. 1992;10 Suppl 1:S40-4
pubmed: 1335657
J Gen Virol. 2003 Dec;84(Pt 12):3191-201
pubmed: 14645901
J Virol. 2008 Feb;82(4):1688-700
pubmed: 18057242
Intervirology. 2010;53(1):15-9
pubmed: 20068336
J Clin Microbiol. 2010 Sep;48(9):3306-15
pubmed: 20592136
Vaccine. 2010 Sep 24;28(41):6653-7
pubmed: 20723630
Wkly Epidemiol Rec. 2012 Jul 13;87(28/29):261–76
pubmed: 22905367
Euro Surveill. 2013 Apr 25;18(17):20468
pubmed: 23647624
Euro Surveill. 2013 Jul 04;18(27):null
pubmed: 23870076
PLoS One. 2013 Sep 17;8(9):e74752
pubmed: 24069343
PLoS One. 2013 Nov 06;8(11):e74546
pubmed: 24223112
Emerg Infect Dis. 2014 Apr;20(4):596-602
pubmed: 24655539
J Virol. 1989 Nov;63(11):4932-7
pubmed: 2552172
Euro Surveill. 2015 Jan 29;20(4):null
pubmed: 25655054
Euro Surveill. 2015 Jul 23;20(29):21192
pubmed: 26227370
PLoS One. 2016 Feb 22;11(2):e0149642
pubmed: 26901877
Lancet. 2016 Oct 8;388(10053):1545-1602
pubmed: 27733282
Euro Surveill. 2017 Jan 26;22(4):
pubmed: 28181904
Euro Surveill. 2017 Feb 2;22(5):
pubmed: 28183391
Euro Surveill. 2017 Feb 2;22(5):
pubmed: 28183392
Euro Surveill. 2017 Feb 23;22(8):
pubmed: 28251892
Lancet Infect Dis. 2017 Oct;17(10):e306-e319
pubmed: 28645862
BMC Infect Dis. 2017 Jul 14;17(1):497
pubmed: 28705178
Euro Surveill. 2017 Jul 20;22(29):null
pubmed: 28749336
MMWR Morb Mortal Wkly Rep. 2017 Sep 22;66(37):999-1000
pubmed: 28934181
Euro Surveill. 2018 Mar;23(9):
pubmed: 29510780
Euro Surveill. 2018 May;23(22):null
pubmed: 29871720
Euro Surveill. 2018 Aug;23(33):
pubmed: 30131095
Euro Surveill. 2018 Sep;23(37):null
pubmed: 30229723
Euro Surveill. 2018 Oct;23(41):null
pubmed: 30326994